Glyphosate and the EU 2015 - 2016

Glyphosate, the active ingredient in Roundup and many other herbicides, was discussed in the EU Parliament on December 1st 2015.

Glyphosate herbicide at work. Photo Vivian Grisogono Glyphosate herbicide at work. Photo Vivian Grisogono

The timing of the meeting was interesting. It clashed with the global summit starting in Paris on Monday November 30th, which captured the media headlines and deflected interest from the glyphosate debate. Yet dealing with glyphosate properly is a matter of immediate urgency in the public interest.

Glyphosate-based herbicides are used around the world in gardens, parks, roadways and commercial agriculture. Common versions used in Croatia are Cidokor and Ouragan. The EU Committee for Environment, Public Health and Food Safety - happily better known by its abbreviation ENVI - will take part in an Exchange of Views (EoV) about glyphosate with the EU Commission, the WHO (World Health Organisation) International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA).

The subject of discussion was whether or not glyphosate had been shown to be a potential cause of cancer in humans. WHO IARC issued a report on March 20th 2015 stating that glyphosate is “probably carcinogenic to humans”, while EFSA's report, published on November 12th 2015, concluded the opposite, asserting that glyphosate is “unlikely to pose a carcinogenic hazard to humans and the evidence does not support classification with regard to its carcinogenic potential according to Regulation (EC) No 1272/2008”. 

Much was at stake. The discussion was aimed at helping the Commission when it came to making its decision on “whether or not to keep glyphosate on the EU list of approved active substances”. Glyphosate is big business. Originally patented by American agrochemical giant Monsanto and first marketed in 1974, the patent was allowed to lapse in 2000, when Monsanto had established its Roundup-ready genetically modified seeds and crops in the international market, following their introduction in 1996. Other companies were then able to produce glyphosate-based herbicides, which are sold in unimaginable quantities worldwide. After publishing articles about the herbicide on its website, our registered charity Eco Hvar received apparently serious offers of partnerships from glyphosate suppliers as far apart as Uganda and China.

Following the publication of the WHO report, many countries imposed restrictions on the sale of glyphosate products to the public. Bermuda went further and suspended all imports of glyphosate and glyphosate-based herbicides.

Is glyphosate proven safe?

No, despite Monsanto's continued assurances. How can a poison be considered safe? It can't be tested on humans, that would provoke outrage. The hundreds of animals which have been force-fed glyphosate in laboratories are no proof of what happens when glyphosate is mixed up for application in the environment. Glyphosate received approval from the American Environmental Protection Agency (EPA) mainly on the basis of research studies which were sponsored by the producers. Most were never published in peer-reviewed journals. The few published articles submitted in support dealt mainly with protocols for dealing with the hapless animals subjected to the poison to see how much would do them harm. Glyphosate was reregistered by the EPA in 1993. Supporting documentation for the approval included some 228 unpublished papers submitted by Monsanto.

Is glyphosate linked to cancers?

 Yes, this showed up in some of the animal testing, and was confirmed in the WHO report.

Why is research linking glyphosate to cancer risks not respected?

The results are respected by those who are guided by true scientific principles. But credible science has been undermined by the profit motive. There have been cover-ups. There is determined lobbying. All those who have vested interests in selling glyphosate products have mountedvirulent campaigns to neutralize any reports suggesting glyphosate is not safe. The most notorious case involved a study by Gilles-Eric Séralini and his team showing several adverse effects of Roundup and genetically modified maize on rats, including tumour formation. Published in 2012, the research paper was retracted by the journal's editor in 2013. The authors stood by their results, and scientists rallied behind the authors. The paper was re-published in 2014.

Is glyphosate generally safe apart from the possible risk of cancers?

No. Glyphosate has been shown to have very many health risks, as well as causing damage to the environment. Glyphosate works by inhibiting the shikimic acid pathway in plants. It was claimed that this pathway did not exist in humans. However, it has been shown that it does exist in the human gut, which is vital to good health. Disturbance of the gut mechanisms is linked to a whole raft of problems and diseases.

Pro-glyphosate reports? barely credible

A review carried out by EU rapporteur state Germany and submitted to the European Food Safety Authority in January 2014 concluded that glyphosate posed no major risks to human health. This raised strong public protest, and there was an even stronger reaction against EFSA's report in November 2015, which was largely based on the 2014 EU report, and obviously produced to counter the WHO IARC's measured stance. The strength of the public disapproval is not surprising, given the wealth of evidence that glyphosate is hazardous.

The Exchange of Views

The EU's Environmental Committee consists of some 139 members, including two from Croatia: Marijana Petir of the Christian Democrats group, and Davor Škrlec of the Greens/European Free Alliance group. Fingers crossed that the committee members don't ever fall for the blandishments or bullying tactics of the pro-glyphosate lobby. Most people, when pressed, define good health as their biggest priority, way ahead of wealth. The health of millions will continue to be in jeopardy if glyphosate's approval for use in the European Union is extended.

The next step

In March 2016, the environmental Committee produced a draft Motion for a non-binding Resolution, in advance of a vote due to take place in an EU Plenary Session on 13th April 2016. When it came to the vote, there were last-minute amendments to the Resolution which significantly altered the nature of the Resolution's proposals. The amended Motion for Resolution was carried by 374 votes to 225, with 102 abstentions. The most controversial alteration was the call to the Commission to renew Glyphosate's approval for a further seven years. Although this was less than the Commission's recommendation of the maximum fifteen years, it caused great disappointment among leading Environment Committee members who felt that this was not in the interests of public health, given the proven risks of Glyphosate use. 

After the vote, Croatian MEP Biljana Borzan, who voted in favour of the Motion for Resolution, expressed the view that the European Commission would probably not dare to ignore the message from the Parliamentarians, even though the Motion was non-binding. However, shortly afterwards the news began to circulate that the Commission was intending to ignore several of the Parliamentary proposals, and to seek a ten-year extension for Glyphosate approval.

With the European Parliament powerless and the Commission all-powerful, serious flaws in the EU's democratic processes became clear during the year following the IARC report. The health of millions of people was left at risk. 

© Vivian Grisogono 2015, updated May 2016 

Video sadržaj

Nalazite se ovdje: Home opasni otrovi Glyphosate and the EU 2015 - 2016

Eco Environment News feeds

Novosti: Cybermed.hr

  • Spektar placenta accreta (PAS) nekada je bio rijetko stanje u trudnoći, ali sada pogađa otprilike 14.000 trudnoća godišnje, što predstavlja glavni uzrok smrti majki. Ipak, zašto se to događa još uvijek nije dobro shvaćeno. Placenta accreta (urasla posteljica) nastaje kada posteljica previše duboko raste u stijenku maternice i ne odvaja se nakon poroda, što često rezultira krvarenjem opasnim po život i potrebom za histerektomijom (kirurški zahvat uklanjanja maternice).

  • Američki znanstvenici s Cleveland Clinic otkrili su da bakterije unutar kancerogenih tumora mogu biti ključne za razumijevanje zašto imunoterapija djeluje kod nekih pacijenata, a kod drugih ne.

  • Prema rezultatima nove studije, izgleda da je težina kronične bolesti bubrega (CKD) povezana s povećanim rizikom od gastropareze. Porast prevalencije gastropareze bio je proporcionalan težini kronične bubrežne bolesti, s najvećom vjerojatnošću uočenom u uznapredovalim stadijima u odnosu na pacijente bez kronične bolesti bubrega.

  • Sve više dokaza upućuje na to da teška bolest desni, parodontitis, može doprinijeti poremećajima središnjeg živčanog sustava putem kronične upale. Međutim, njegova uloga u multiploj sklerozi, kroničnoj autoimunoj bolesti središnjeg živčanog sustava, nije bila jasna. No, rezultati nove studije upućuju na potencijalnu povezanost između relativne brojnosti Fusobacterium nucleatum, bakterije koja se nalazi u ustima, i težine bolesti kod pacijenata s multiplom sklerozom.

  • Rezultati nove studije ukazuju na potencijalne terapijske učinke dihidrotanshinona I (DHT), spoja dobivenog iz tradicionalne kineske biljke Salvia miltiorrhiza, na rak jajnika. Istraživanje, koje su proveli kineski znanstvenici sa Zhejiang Chinese Medical University i Jiangsu Normal University, otkriva da dihidrotanshinon I može izazvati autofagnu staničnu smrt u stanicama raka jajnika ometanjem puta autofagije-lizosoma posredovanog sortilinom 1 (SORT1).

  • Nedavno objavljena studija bacila je novo svjetlo na ulogu proteina NSUN2 u razvoju srčane hipertrofije i zatajenja srca. Naime, istraživanje, koje su proveli kineski znanstvenici s Harbin Medical University pokazalo je, da NSUN2, član obitelji domena NOL1/NOP2/Sun, značajno doprinosi patološkoj srčanoj hipertrofiji aktiviranjem osi LARP1-GATA4, potencijalno nudeći novu terapijsku metu za zatajenje srca.

  • Gestacijski dijabetes, stanje, koje povećava zdravstvene rizike i za majku i za dijete, poraslo je u SAD-u za 36% tijekom devetogodišnjeg razdoblja (s 58 na 79 slučajeva na 1.000 poroda) i povećalo se u svim rasnim i etničkim skupinama, pokazala je nova studija.

  • Briga oko spajanja kraja s krajem stari vaše srce jednako kao i klasični čimbenici rizika za srčane bolesti, tvrdi nova studija. Naime, pokazalo se, da su financijski pritisak i nesigurnost u vezi s hranom najjači pokretači ubrzanog starenja srca.

  • Nakon traumatske ozljede mozga, neki se pacijenti mogu potpuno oporaviti, dok drugi zadržavaju teške invaliditete. Točna procjena prognoze je izazovna kod pacijenata na terapiji održavanja života. Iako funkcionalna magnetska rezonancija u mirovanju (rs-fMRI) može procijeniti neurološku aktivnost ubrzo nakon ozljede mozga, nije poznato predviđa li komunikacija između regija mozga u ovom ranom trenutku dugoročni oporavak.

  • Diljem svijeta uobičajene infekcije postaju sve teže za liječiti. Novi pregled prikazuje otrežnjujuću sliku globalne antimikrobne rezistencije (AMR), prateći kako se bakterije i gljivice razvijaju brže nego što medicina može reagirati. Uspoređujući podatke o rezistenciji iz više sustava nadzora, znanstvenici su identificirali alarmantne trendove: rastuću otpornost na antibiotike posljednje linije, regionalne nejednakosti i brzo širenje rezistentnih gena putem globalnih putovanja i poljoprivrede.

Novosti: Biologija.com

Izvor nije pronađen